Grannum Sant, M.D., F.R.C.S., F.A.C.S.
Dr. Grannum Sant is a renowned key opinion leader (KOL) in the fields of urology and oncology in men’s and women’s health. He served as the Professor and Chair of Urology at Tufts University School of Medicine prior to joining the pharmaceutical industry as the Vice-President of Medical Affairs in Oncology and Urology at Sanofi-Aventis. He subsequently served as the Head of US and Global Medical Affairs at Genzyme and has retained his academic appointment as Professor of Urology at Tufts University School of Medicine. He currently serves as a Senior Medical Director at OPKO Urology, chairs the Scientific Advisory Board for Cellanyx Diagnostics, and is a member of EmpiraMed’s SAB. Dr. Sant is a board certified physician in adult and pediatric urology and is the President-Elect of the Academy of Physicians in Clinical Research. He received his medical degree from Trinity College in Dublin (Ireland) and completed his residencies in general surgery at Albert Einstein College of Medicine (NY) and Royal College of Surgeons (Scotland). He subsequently completed his residency in urology at Tufts University School of Medicine and received his Fellowships from the Royal College of Surgeons (FRCS) and American College of Surgeons (FACS). Dr. Sant is an accomplished physician-scientist and has published widely in the fields of urology and cystitis and received multiple research grants for his research initiatives.
View Curriculum Vitae